Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity

The antiangiogenic agent bevacizumab showed synergistic effects when combined with chemotherapy in advanced breast cancer. We presently investigated the activity of bevacizumab in combination with chemotherapy, including capecitabine and vinorelbine, and endocrine therapy, including letrozole (+trip...

Descripción completa

Detalles Bibliográficos
Autores principales: Torrisi, R, Bagnardi, V, Cardillo, A, Bertolini, F, Scarano, E, Orlando, L, Mancuso, P, Luini, A, Calleri, A, Viale, G, Goldhirsch, A, Colleoni, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584958/
https://www.ncbi.nlm.nih.gov/pubmed/18941458
http://dx.doi.org/10.1038/sj.bjc.6604741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584958/
https://www.ncbi.nlm.nih.gov/pubmed/18941458
http://dx.doi.org/10.1038/sj.bjc.6604741

Ejemplares similares